Neuron-Specific Enolase
Also known as: NSE
What Does Neuron-Specific Enolase Measure?
Neuron-Specific Enolase (NSE) is a protein enzyme found predominantly in neurons (nerve cells) and neuroendocrine cells throughout the body. A blood test for NSE measures the concentration of this enzyme circulating in the bloodstream, which under normal circumstances is very low. NSE is one of three isoforms of the glycolytic enzyme enolase, and its presence in measurable quantities in blood typically indicates that neural or neuroendocrine tissue has been damaged or disrupted, allowing the enzyme to leak into the circulation.
Why Does Neuron-Specific Enolase Matter?
NSE serves as an important clinical biomarker for two primary purposes: as a tumor marker for certain cancers and as an indicator of neurological injury. In oncology, elevated NSE levels are associated with small cell lung cancer (SCLC) and neuroendocrine tumors, helping doctors monitor treatment response and detect recurrence. In neurology and critical care, NSE is used to assess the severity of brain injury following events such as cardiac arrest, stroke, traumatic brain injury, or hypoxic-ischemic encephalopathy. Rising NSE levels after such events suggest ongoing neuronal death and can help predict neurological outcomes, guiding critical treatment decisions.
Normal Ranges
Males
< 16.3 ng/mL (some labs use < 12.5 ng/mL)
Females
< 16.3 ng/mL (some labs use < 12.5 ng/mL)
Children
Varies by age; neonates may have higher baseline levels (up to 30 ng/mL); consult age-specific reference ranges
Causes of High Levels
- Small cell lung cancer (SCLC) — NSE is a classic tumor marker for this aggressive malignancy
- Neuroendocrine tumors — including carcinoid tumors, pheochromocytoma, and pancreatic neuroendocrine tumors
- Traumatic brain injury or stroke — neuronal cell death releases NSE into the bloodstream
- Cardiac arrest or hypoxic-ischemic brain injury — widespread neuronal damage elevates NSE significantly
- Neuroblastoma — a childhood cancer of the sympathetic nervous system commonly associated with high NSE
- Hemolysis — red blood cells also contain enolase, so hemolyzed samples can cause falsely elevated NSE readings
Causes of Low Levels
- No established clinical significance for low NSE levels — values below the reference range are generally not medically concerning
- Absence of active neuroendocrine tumor — successful treatment of NSE-secreting cancers leads to declining levels
How to Improve Your Neuron-Specific Enolase
Diet
- Adopt a Mediterranean-style diet rich in fruits, vegetables, whole grains, and healthy fats to support overall neuronal health
- Increase omega-3 fatty acid intake through fatty fish (salmon, sardines, mackerel) 2-3 times per week to support neuroprotection
- Limit processed foods, refined sugars, and trans fats that promote systemic inflammation and may worsen neuronal stress
- Ensure adequate antioxidant intake through colorful vegetables and berries to combat oxidative damage to neurons
- Stay well hydrated — dehydration can exacerbate neurological stress and impair brain function
Supplements
- Omega-3 fatty acids (EPA/DHA): 1,000–3,000 mg/day may support neuroprotection (consult a doctor before use)
- Vitamin D3: 1,000–2,000 IU/day if deficient, as low vitamin D is linked to poorer neurological outcomes
- Magnesium glycinate: 200–400 mg/day, which supports nerve function and may reduce excitotoxic neuronal damage
- Alpha-lipoic acid: 300–600 mg/day as an antioxidant with demonstrated neuroprotective properties in research settings
- B-complex vitamins (B6, B9, B12) to support neurological function and reduce homocysteine, a neurotoxic amino acid
Related Biomarkers
Frequently Asked Questions
What does it mean if my NSE level is elevated?
An elevated NSE level can indicate two main things: either damage to neurons (brain or nerve cells) from events like stroke, cardiac arrest, or head injury, or the presence of a neuroendocrine tumor such as small cell lung cancer or neuroblastoma. A single elevated value should always be interpreted in the context of your symptoms, medical history, and other test results. Your doctor may order additional imaging or tests to determine the underlying cause.
Is NSE a reliable cancer marker?
NSE is most useful as a tumor marker for small cell lung cancer (SCLC) and neuroendocrine tumors. It is used primarily to monitor treatment response and detect recurrence rather than as a standalone screening tool. Its specificity is limited because NSE can also be elevated due to non-cancerous causes such as brain injury or hemolysis. For this reason, it is typically used alongside other markers such as Pro-GRP for SCLC, or Chromogranin A for neuroendocrine tumors.
Can hemolysis affect my NSE test results?
Yes, significantly. Red blood cells contain enolase, and when a blood sample is hemolyzed (meaning red blood cells break down during or after collection), the enolase released can falsely elevate the NSE reading. Laboratories routinely check for hemolysis before reporting NSE results, and hemolyzed samples are typically rejected and the test repeated with a fresh sample. This is one reason why proper blood collection technique is very important for accurate NSE testing.
How is NSE used after cardiac arrest or brain injury?
In intensive care settings, serial NSE measurements taken 24–72 hours after cardiac arrest or a major brain injury are used to help assess the extent of neuronal damage and predict neurological outcomes. Higher or rising NSE levels during this window generally correlate with more severe brain injury and a worse prognosis. However, NSE is never used in isolation — it is interpreted alongside clinical neurological examinations, EEG findings, and imaging studies such as MRI.